Liu Min, Liu Bailong, Liu Bin, Cui Xiangyan, Yang Shuo, Wang Qiang, Dong Lihua
From the Department of Radiation Oncology (ML, BL, SY, QW, LD); Department of Hand Surgery (BL); and Department of Otolaryngology (XC), The First Hospital, Jilin University, Changchun, China.
Medicine (Baltimore). 2015 May;94(17):e788. doi: 10.1097/MD.0000000000000788.
The clinicopathological characteristics and rational treatment of primary laryngeal mucosa-associated lymphoid tissue (MALT) lymphoma are still unclear and need to be further defined due to the paucity of this separate lymphoma.Herein, a supraglottic primary MALT lymphoma was described with detailed clinical course, intervention, and follow-up. To date, research of laryngeal MALT lymphoma has seldom been initiated. Our experience in this case will help to expand our understanding of this unique disease. A 58-year-old female presented with a history of progressive hoarseness for about 10 months. Multiple laryngoscopy examinations revealed severe hypertrophy of left ventricular band. She was admitted to our department with residual MALT lymphoma of supraglottic region after partial resection by laser. After systemic evaluation, she was staged as IEA, International Prognostic Index score 0. Irradiation of intensity modulated radiotherapy technique with a dose of 30.6 Gy/17f to the tumor and 25.5 Gy/17f to the related lymphatic drainage area achieved a complete remission. The disease-free survival has reached to 4 years. The irradiation related acute and late side effects were mild.Radiotherapy is the first option for limited-stage primary laryngeal MALT lymphoma because of excellent treatment outcome.
原发性喉黏膜相关淋巴组织(MALT)淋巴瘤的临床病理特征及合理治疗仍不明确,由于这种罕见淋巴瘤病例较少,尚需进一步明确。在此,我们描述了1例声门上型原发性MALT淋巴瘤的详细临床过程、干预措施及随访情况。迄今为止,针对喉MALT淋巴瘤的研究很少。我们对该病例的经验将有助于拓展对这种独特疾病的认识。1例58岁女性患者,有渐进性声音嘶哑病史约10个月。多次喉镜检查显示左室带严重肥大。她因激光部分切除术后声门上区残留MALT淋巴瘤入住我科。经过全面评估,她被分期为IEA期,国际预后指数评分为0。采用调强放疗技术,给予肿瘤30.6 Gy/17次分割照射,相关淋巴引流区25.5 Gy/17次分割照射,实现了完全缓解。无病生存期已达4年。放疗相关的急、晚期不良反应均较轻。由于治疗效果良好,放疗是局限性原发性喉MALT淋巴瘤的首选治疗方法。